Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sickness funds could lose DM400 million:

This article was originally published in Clinica

Executive Summary

In Germany, the overall contribution rate of pensioners attached to statutory health insurance schemes is set to rise. The increase will compensate the funds for a potential loss of income caused by a reduction in contributions by pensioners who, during their working lives, opted to join private funds and have since returned to the statutory scheme. The move, which may cost the sickness funds up to DM400 million ($185 million), comes as a result of a court decision which ruled that pensioners who voluntarily returned to statutory funds were charged too much. The government has until March 2002 to change the law.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT070956

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel